↓ Skip to main content

On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients

Overview of attention for article published in Frontiers in Pharmacology, January 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
110 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients
Published in
Frontiers in Pharmacology, January 2020
DOI 10.3389/fphar.2019.01664
Pubmed ID
Authors

Ciska Verbaanderd, Ilse Rooman, Lydie Meheus, Isabelle Huys

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 110 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 17 15%
Student > Bachelor 13 12%
Researcher 10 9%
Student > Doctoral Student 8 7%
Student > Ph. D. Student 5 5%
Other 11 10%
Unknown 46 42%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 24 22%
Medicine and Dentistry 10 9%
Biochemistry, Genetics and Molecular Biology 6 5%
Social Sciences 5 5%
Nursing and Health Professions 5 5%
Other 14 13%
Unknown 46 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 March 2020.
All research outputs
#7,850,346
of 24,338,161 outputs
Outputs from Frontiers in Pharmacology
#3,495
of 18,279 outputs
Outputs of similar age
#161,392
of 459,235 outputs
Outputs of similar age from Frontiers in Pharmacology
#127
of 450 outputs
Altmetric has tracked 24,338,161 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 18,279 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 459,235 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 450 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.